AQR Capital Management
ORMP icon

AQR Capital Management’s Oramed Pharmaceuticals ORMP Stock Holding History

AQR Capital Management’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,954
Closed -$155K – 2267
2022
Q1 		$155K Sell
17,954
-2,021
-10% -$20.7K ﹤0.01% 2101
2021
Q4 		$285K Sell
19,975
-2,596
-12% -$54.3K ﹤0.01% 1996
2021
Q3 		$496K Buy
+22,571
New +$384K ﹤0.01% 1868

Other funds holding ORMP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management's ORMP Position: Q2 2022 in Review

AQR Capital Management sold out of Oramed Pharmaceuticals (ORMP) in Q2 2022, closing a stake of 17,954 shares — an estimated $155K sold.

AQR Capital Management first reported a position in ORMP in Q3 2021 and held it in 3 quarters. The position peaked at $496K in Q3 2021. 88 funds tracked by Wall St. Rank hold ORMP as of Q2 2022.

  • AQR Capital Management reported no remaining Oramed Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • AQR Capital Management sold 17,954 Oramed Pharmaceuticals shares in Q2 2022, an estimated $155K.
  • AQR Capital Management first reported a position in Oramed Pharmaceuticals in Q3 2021 and held it in 3 quarters.
  • AQR Capital Management's Oramed Pharmaceuticals position peaked at $496K in Q3 2021.
  • 88 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2022.

Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.